IGF-IR/ERK content and response to IGF-I and insulin in adipocytes from small for gestational age children

Growth Hormone and IGF Research

Volumn 19, Issue 3, 2009, Pages 256-261

  Iñiguez, German ^a   Ormazabal, Paulina ^a   López, Teresa ^b   Maldonado, Diego ^b   Avila, Alejandra ^a   Román, Rossana ^a   Cassorla, Fernando ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL SAN BORJA ARRIARÁN   (Chile)

Author keywords

Adipocytes; ERK; IGF I; Insulin like growth factor receptor; Small for gestational age (SGA)

Indexed keywords

INSULIN; INSULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADIPOCYTE; ARTICLE; BODY HEIGHT; BODY MASS; CELL CULTURE; CELL DIFFERENTIATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; METABOLIC DISORDER; PREPUBERTY; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN CONTENT; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMALL FOR DATE INFANT; SUBCUTANEOUS FAT;

ADIPOCYTES; BLOTTING, WESTERN; CHILD; FEMALE; GESTATIONAL AGE; HUMANS; HYPOGLYCEMIC AGENTS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PUBERTY; RECEPTOR, IGF TYPE 1; THYROTROPIN; THYROXINE;

EID: 67349122684     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2008.12.005     Document Type: Article

References (26)

1. Fliesen T., Maiter D., Gerard G., Underwood L.E., Maes M., and Ketelslegers J.M. Reduction of serum insulin-like growth factor-I by dietary protein restriction is age dependent. Pediatr. Res. 26 (1989) 415-419
2. Holl R.W., Snehotta R., Siegler B., Scherbaum W., and Heinze E. Binding protein for human growth hormone: effects of age and weight. Horm Res. 35 (1991) 190-197
3. Combettes-Souverain M., and Issad T. Molecular basis of insulin action. Diabetes Metab. 24 (1998) 477-489
4. Butler A.A., Yakar S., Gewolb I.H., Karas M., Okubo Y., and LeRoith D. Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 121 (1998) 19-26
5. Entingh-Pearsall A., and Kahn C.R. Differential roles of the insulin and insulin-like growth factor-I (IGF-I) receptors in response to insulin and IGF-I. J. Biol. Chem. 279 (2004) 38016-38024
6. Datta S.R., Brunet A., and Greenberg M. Cellular survival: a play in three Akts. Genes Dev. 13 (1999) 2905-2927
7. Spiegelman B.M., and Flier J.S. Adipogenesis and obesity: rounding out the big picture. Cell 87 (1996) 377-389
8. Hauner H., Entenmann G., Wabitsch M., Gaillard D., Ailhaud G., Negrel R., and Pfeiffer E.F. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J. Clin Invest. 84 (1989) 1663-1670
9. Ozanne S.E., Jensen C.B., Tingey K.J., Martin-Gronert M.S., Grunnet L., Brons C., Storgaard H., and Vaag A.A. Decreased protein levels of key insulin signaling molecules in adipose tissue from young men with a low birthweight - potential link to increased risk of diabetes?. Diabetologia 49 (2006) 2993-2999
10. Roman R., Iñiguez G., Salazar T., Avila A., Barrera A., Mericq V., Attie K.M., and Cassorla F. Relationship between insulin sensitivity and IGF-I sensitivity in low birth weight prepubertal children. Horm. Res. 70 2 (2008) 73-78
11. Juez G., Lucero E., Ventura-Junca P., Tapia J., Gonzalez H., and Winter A. Estudio neonatal del crecimiento intrauterino en 11543 recién nacidos chilenos de clase media 1978-1987. Rev. Chil Pediatr. 60 (1989) 198-202
12. Cifuentes L., Valenzuela C.Y., Cruz-Coke R., Armanet L., Lyng C., and Harb Z. Genetic characterization of the hospital population of Santiago. Rev. Med. Chile 116 (1988) 28-33
13. Iniguez G., Ong K., Bazaes R., Avila A., Salazar T., Dunger D., and Mericq V. Longitudinal changes in IGF-I, insulin sensitivity and secretion from birth to age three years in small-for-gestational-age children. J. Clin Endocrinol. Metab. 91 (2006) 4645-4649
14. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 227 (1970) 680-685
15. Abuzzahab M.J., Schneider A., Goddard A., Grigorescu F., Lautier C., Keller E., Kiess W., Klammt J., Kratzsch J., Osgood D., Pfaffle R., Raile K., Seidel B., Smith R.J., and Chernausek S.D. Intrauterine growth retardation (IUGR) study group: IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl. J. Med. 349 (2003) 2211-2222
16. Taylor R., Husband D.J., Marshall S.M., Tunbridge W.M., and Alberti K.G. Adipocyte insulin binding and insulin sensitivity in 'brittle' diabetes. Diabetologia 27 (1984) 441-446
17. Lönnroth P., Blohmé G., Lager I., Tisell L.E., and Smith U. Insulin resistance in fat cells from insulin-treated type I diabetic individuals. Diabetes Care 6 (1983) 586-590
18. Borissova A.M., Tankova T.I., and Koev D.J. Insulin secretion, peripheral insulin sensitivity and insulin-receptor binding in subjects with different degrees of obesity. Diabetes Metab. 30 (2004) 425-431
19. Ozanne S.E., Jensen C.B., Tingey K.J., Storgaard H., Madsbad S., and Vaag A.A. Low birthweight is associated with specific changes in muscle insulin-signaling protein expression. Diabetologia 48 (2005) 547-552
20. Ozanne S.E., Dorling M.W., Wang C.L., and Nave B.T. Impaired PI 3-kinase activation in adipocytes from early growth-restricted male rats. Am. J. Physiol. Endocrinol. Metab. 280 (2001) E534-E539
21. Ozanne S.E., Olsen G.S., Hansen L.L., Tingey K.J., Nave B.T., Wang C.L., Hartil K., Petry C.J., Buckley A.J., and Mosthaf-Seedorf L. Early growth restriction leads to down-regulation of protein kinase C zeta and insulin resistance in skeletal muscle. J. Endocrinol. 177 (2003) 235-241
22. Bost F., Aouadi M., Caron L., Even P., Belmonte N., Prot M., Dani C., Hofman P., Pages G., Pouyssegur J., Le Marchand-Brustel Y., and Binetruy B. The extracellular signal-regulated kinase isoform ERK1 is specifically required for in-vitro and in-vivo adipogenesis. Diabetes 54 (2005) 402-411
23. Hara K., Yonezawa K., Sakaue H., Ando A., Kotani K., Kitamura T., Kitamura Y., Ueda H., Stephens L., Jackson T.R., Hawkins P.T., Dhand R., Clark A.E., Holman G.D., Waterfield M.D., and Kasuga M. Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc. Natl. Acad. Sci. USA 91 (1994) 7415-7419
24. Okada T., Kawano Y., Sakakibara T., Hazeki O., and Ui M. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes: studies with a selective inhibitor wortmannin. J. Biol. Chem. 269 (1994) 3568-3573
25. Alessi D.R., and Downes C.P. The role of PI 3-kinase in insulin action. Biochim. Biophys. Acta 1436 (1998) 151-164
26. Carvalho E., Eliasson B., Wesslau C., and Smith U. Impaired phosphorylation and insulin-stimulated translocation to the plasma membrane of protein kinase B/Akt in adipocytes from type II diabetic subjects. Diabetologia 43 (2000) 1107-1115